Is Nanoviricides going out of business?

NANOVIRICIDES, INC. (NNVC) Fundamentals

A quick summary of the latest filed figures while the full analysis loads.

NANOVIRICIDES, INC. (NNVC) scores 15 out of 100 on fundamentals, Distressed / Caution, based on SEC filing data.

Leading signal: Filing event risk: Going-Concern Warning (-8 pts)

Five questions, kept separate

Survival - Critical

3-6 mo of estimated runway from 2026-03-31, based on $3.2M of cash and short-term investments against $8.5M of annual burn. Adjusted shares outstanding increased 32.1% over the comparison year.

Business quality - Pre-commercial

Operating margins cannot grade a pipeline; Survival and clinical evidence remain the relevant lenses here.

Trajectory - Clinical progress unavailable

Fundamentals can show funding and burn, but not whether the clinical pipeline is advancing.

Valuation - Demanding

0.2% net-cash backing support a demanding pre-commercial Valuation assessment.

Event risk - Critical event risk

Going-Concern Warning is the decisive filing event; one adverse event family is active. It appears across 3 scanned filings. Favorable events are shown separately and do not offset adverse risk.

What the rules read

• Filing event risk: Going-Concern Warning (-8 pts)
• Cash Runway (years): 0.38y
• Shares dilution YoY: 32.09% (YoY)
• Return on Assets: -92.64%
• Price / Earnings: Unprofitable (see Valuation)

Read from filings through 2026-07-30.

Price as of 2026-09-07.